Skip to main content
Erschienen in: Acta Neurochirurgica 11/2011

01.11.2011 | Clinical Article

Predictive role of modified clinical diffusion mismatch in early neurological deterioration due to atherothrombotic ischemia in the anterior circulation

verfasst von: Atsushi Saito, Hiroaki Shimizu, Miki Fujimura, Takashi Inoue, Teiji Tominaga

Erschienen in: Acta Neurochirurgica | Ausgabe 11/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Atherothrombotic ischemia is the most frequent cause of cerebral ischemia; however, few reports have addressed the prognostic factors predicting early neurological deterioration (END) when the occlusive lesion is limited to the anterior main trunk, middle cerebral artery (MCA) or internal cerebral artery (ICA).

Method

Between 2006 and 2008, 122 atherothrombotic ischemia patients were diagnosed with MCA or ICA occlusive disease on magnetic resonance angiography. The National Institutes of Health Stroke Scale (NIHSS) score and the modified Alberta Stroke Program Early CT Score on diffusion-weighted imaging [ASPECTS-DW (modified)] were calculated. Clinical-DWI mismatch (CDM) was evaluated using NIHSS and the ASPECTS-DW (modified) to examine the predictive efficacy for early neurological deterioration.

Results

Eighteen of 122 (14.8%) patients fulfilled the definition of CDM. END was observed in 24 patients (19.7%) within 15 days after admission. CDM was observed in 14 cases in the END (+) group (14 of 24 cases, 58.3%) and 4 cases in the END (−) group (4 of 98 cases, 4.1%) (p = 0.001). Multivariate logistic regression analysis demonstrated that CDM was a significant predictive factor of END (odds ratio 26.68, p = 0.0001).

Conclusions

CDM based on NIHSS and ASPECTS-DW (modified) could be a significant predictive factor for END of atherothrombotic ischemia in MCA/ICA.
Literatur
1.
Zurück zum Zitat Arenillas JF, Alvarez-Sabin J, Molina CA, Chacon P, Montaner J, Rovira A, Ibarra B, Quntana M (2003) C-reactive protein predicts further ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 34:2463–2470PubMedCrossRef Arenillas JF, Alvarez-Sabin J, Molina CA, Chacon P, Montaner J, Rovira A, Ibarra B, Quntana M (2003) C-reactive protein predicts further ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 34:2463–2470PubMedCrossRef
2.
Zurück zum Zitat Astrup J, Siesjo BK, Symon L (1981) Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 12:723–725PubMedCrossRef Astrup J, Siesjo BK, Symon L (1981) Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 12:723–725PubMedCrossRef
3.
Zurück zum Zitat Barber PA, Demchuk AM, Zhang J, Buchan AM, for the ASPECTS Study Group (2000) Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombotic therapy. Lancet 355:1670–1674PubMedCrossRef Barber PA, Demchuk AM, Zhang J, Buchan AM, for the ASPECTS Study Group (2000) Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombotic therapy. Lancet 355:1670–1674PubMedCrossRef
4.
Zurück zum Zitat Darby DG, Barber PA, Gerraty RP, Desmond PM, Yang Q, Parsons M, Li T, Tress BM, Davis SM (1999) Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke 30:2043–2052PubMedCrossRef Darby DG, Barber PA, Gerraty RP, Desmond PM, Yang Q, Parsons M, Li T, Tress BM, Davis SM (1999) Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke 30:2043–2052PubMedCrossRef
5.
Zurück zum Zitat Davalos A, Blanco M, Pedraza S, Leira R, Castellanos M, Pumar JM, Silva Y, Serena J, Castillo J (2004) The clinical-DWI mismatch. A new diagnostic approach to the brain tissue at risk of infarction. Neurology 62:2187–2192PubMed Davalos A, Blanco M, Pedraza S, Leira R, Castellanos M, Pumar JM, Silva Y, Serena J, Castillo J (2004) The clinical-DWI mismatch. A new diagnostic approach to the brain tissue at risk of infarction. Neurology 62:2187–2192PubMed
6.
Zurück zum Zitat DeGraba TJ, Hallenbeck JM, Pettigrew KD, Dutka AJ, Kelly BJ (1999) Progression in acute stroke: value of the initial NIH Stroke Scale score on patient stratification in future trials. Stroke 30:1208–1212PubMedCrossRef DeGraba TJ, Hallenbeck JM, Pettigrew KD, Dutka AJ, Kelly BJ (1999) Progression in acute stroke: value of the initial NIH Stroke Scale score on patient stratification in future trials. Stroke 30:1208–1212PubMedCrossRef
7.
Zurück zum Zitat Deguchi I, Takeda H, Furuya D, Hattori K, Dembo T, Nagoya H, Kato Y, Fukuoka T, Maruyama H, Tanahashi N (2011) Significance of clinical diffusion mismatch in hyperacute cerebral infarction. J Stroke Cerebrovasc Dis 20:62–70PubMedCrossRef Deguchi I, Takeda H, Furuya D, Hattori K, Dembo T, Nagoya H, Kato Y, Fukuoka T, Maruyama H, Tanahashi N (2011) Significance of clinical diffusion mismatch in hyperacute cerebral infarction. J Stroke Cerebrovasc Dis 20:62–70PubMedCrossRef
8.
Zurück zum Zitat Gorelick PB, Wong KS, Bae HJ, Pandey DK (2008) Large artery intracranial occlusive disease. A large worldwide burden but a relative neglected frontier. Stroke 39:2396–2399PubMedCrossRef Gorelick PB, Wong KS, Bae HJ, Pandey DK (2008) Large artery intracranial occlusive disease. A large worldwide burden but a relative neglected frontier. Stroke 39:2396–2399PubMedCrossRef
9.
Zurück zum Zitat Hill MD, Rowley HA, Adler F, Elasziw M, Furlan A, Higashida RT, Wechsler LR, Roberts HC, Dillon WP, Fischbein NJ, Firszt CM, Schulz GA, Buchan AM, for the PROACT-II Investigators (2003) Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 34:1925–1931PubMedCrossRef Hill MD, Rowley HA, Adler F, Elasziw M, Furlan A, Higashida RT, Wechsler LR, Roberts HC, Dillon WP, Fischbein NJ, Firszt CM, Schulz GA, Buchan AM, for the PROACT-II Investigators (2003) Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 34:1925–1931PubMedCrossRef
10.
Zurück zum Zitat Hillis AE, Wityk RJ, Barker PB, Ulatowski JA, Jacobs MA (2003) Changes in perfusion in acute nondominant hemisphere stroke may be better estimated by tests of hemispatial neglect than by the National Institutes of Health Stroke Scale. Stroke 34:2392–2398PubMedCrossRef Hillis AE, Wityk RJ, Barker PB, Ulatowski JA, Jacobs MA (2003) Changes in perfusion in acute nondominant hemisphere stroke may be better estimated by tests of hemispatial neglect than by the National Institutes of Health Stroke Scale. Stroke 34:2392–2398PubMedCrossRef
11.
Zurück zum Zitat Hirai T, Sasaki M, Maeda M, Ida M, Katsuragawa S, Sakoh M, Takano K, Arai S, Hirano T, Kai Y, Kakeda S, Murakami R, Ikeda R, Fukuoka H, Sasano A, Yamashita Y (2009) Acute Stroke Imaging Standardization Group-Japan (ASIST-Japan) investigators. Acad Radiol 16:305–312PubMedCrossRef Hirai T, Sasaki M, Maeda M, Ida M, Katsuragawa S, Sakoh M, Takano K, Arai S, Hirano T, Kai Y, Kakeda S, Murakami R, Ikeda R, Fukuoka H, Sasano A, Yamashita Y (2009) Acute Stroke Imaging Standardization Group-Japan (ASIST-Japan) investigators. Acad Radiol 16:305–312PubMedCrossRef
12.
Zurück zum Zitat Prosser J, Butcher K, Allport L, Parsons M, MacGregor L, Desmond P, Tress B, Davis S (2006) Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke 36:1700–1704CrossRef Prosser J, Butcher K, Allport L, Parsons M, MacGregor L, Desmond P, Tress B, Davis S (2006) Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke 36:1700–1704CrossRef
13.
Zurück zum Zitat Sasaki M, Yamada K, Watanabe Y, Matsui M, Ida M, Fujiwara S, Shibata E, Acute Stroke Imaging Standardization Group-Japan (ASIST-Japan) (2008) Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multiinstitutional comparison study. Radiology 249:624–630PubMedCrossRef Sasaki M, Yamada K, Watanabe Y, Matsui M, Ida M, Fujiwara S, Shibata E, Acute Stroke Imaging Standardization Group-Japan (ASIST-Japan) (2008) Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multiinstitutional comparison study. Radiology 249:624–630PubMedCrossRef
14.
Zurück zum Zitat Sobesky J, Weber OZ, Lehnhardt FG, Hesselmann V, Neveling M, Jacobs A, Heiss WD, Does the mismatch match the penumbra? (2005) Magnetic resonance imaging and position emission tomography in early ischemic stroke. Stroke 36:980–985PubMedCrossRef Sobesky J, Weber OZ, Lehnhardt FG, Hesselmann V, Neveling M, Jacobs A, Heiss WD, Does the mismatch match the penumbra? (2005) Magnetic resonance imaging and position emission tomography in early ischemic stroke. Stroke 36:980–985PubMedCrossRef
15.
Zurück zum Zitat Tei H, Uchiyama S, Usui T (2007) Clinical-diffusion mismatch defined by NIHSS and ASPECTS in non-lacunar anterior circulation. J Neurol 254:340–346PubMedCrossRef Tei H, Uchiyama S, Usui T (2007) Clinical-diffusion mismatch defined by NIHSS and ASPECTS in non-lacunar anterior circulation. J Neurol 254:340–346PubMedCrossRef
16.
Zurück zum Zitat The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1588CrossRef The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1588CrossRef
17.
Zurück zum Zitat The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (2000) Effects of intravenous recombinant tissue plasminogen activator on ischemic lesion size measured by computed tomography. Stroke 31:2912–2919CrossRef The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (2000) Effects of intravenous recombinant tissue plasminogen activator on ischemic lesion size measured by computed tomography. Stroke 31:2912–2919CrossRef
18.
Zurück zum Zitat The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group (1998) Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke 29:1389–1392CrossRef The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group (1998) Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke 29:1389–1392CrossRef
Metadaten
Titel
Predictive role of modified clinical diffusion mismatch in early neurological deterioration due to atherothrombotic ischemia in the anterior circulation
verfasst von
Atsushi Saito
Hiroaki Shimizu
Miki Fujimura
Takashi Inoue
Teiji Tominaga
Publikationsdatum
01.11.2011
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 11/2011
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-011-1084-4

Weitere Artikel der Ausgabe 11/2011

Acta Neurochirurgica 11/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.